Learn about what we currently know about the efficacy and safety of COVID-19 vaccines for people with blood cancers. You'll hear about the first Canada-wide study that’s underway to guide public health policies specifically for people with blood cancers following a COVID-19 vaccination and what you can do now to stay safe.
Sita Bhella MD MEd FRCPC
Princess Margaret Cancer Centre (PMCC)
Division of Medical Oncology and Hematology
Department of Medicine
Dr. Bhella is a graduate of Western University’s medical school. She completed her internal medicine and hematology residency at the University of Toronto and a fellowship in Leukemia and Allogeneic Bone Marrow Transplant Fellowship at PMCC.
In 2019, Dr. Bhella joined PMCC, as an assistant professor and a clinician in quality improvement and innovation. She is Quality Lead of the Autologous Stem Cell Transplant Program and is engaged and involved in the development of CAR T-cell therapy program, particularly the long-term survivorship program.